Cyanotech (CYAN) 10-K2014 FY Annual report

Filed: 27 Jun 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: administering, againstCyanotech, allege, alleging, ameliorating, andBioAstin, andInter, anInter, Appeal, barring, block, book, brain, broadly, central, clicking, compensatory, cord, costly, Court, curve, cv, dba, dedicated, defense, degeneration, degenerative, density, depositionson, destroy, discovery, distracting, District, divert, encumbered, entitling, expert, extensive, false, farming, Field, flavor, Florida, footnote, forBioAstin, formula, frequency, grew, HawaiianBioAstin, HawaiianSpirulina, hearing, ii, indirect, induced, injunction, injunctive, injury, inOperating, intentional, intertwined, inthefourth, intraocular, introducedBioAstin, invalid, invalidity, Invention, IPR, ischemic, iv, ix, Lanham, launched, lawsuit, lessee, licensee, macular, Middle, misuse, moot, mortgage, naturalSpirulina, neuronal, notice, Ocala, ofa, ofBioAstin, ofSpirulina, orPhytoDome, ourBioAstin, OurIntegrated, ourspirulina, outcome, Owner, Pacifica®in, page, PartesReview, Petition, petitioned, possession, preliminary, pretax, Procedure, prospective, PTAB, quantity, referencing, relief, rendered, retarding, retina, retinal, science, seeRisk, slightly, Sought, Spearmint, spinal, suffering, suit, superfood, termination, testimony, theInter, thePhytoDome, thespirulina, ThyssenKrupp, traumatic, treble, unenforceability, unfair, University, unlawful, vi, vii, viii, violation

Removed: assessed, compliant, conclude, ensuring, formally, generate, immaterial, Integrated, Internet, ISO, mainstream, manufacturer, PhytoDome, qualification, renewed, seasonally, sourcing, supplied, unit

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CYAN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of CEO and CFO

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Cyanotech Corporation (the “Company”) on Form 10-K for the period ended March 31, 2013 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, each of the undersigned certifies that:

1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act (15 U.S.C. 78m or 78o (d)); and

2)	The information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.

Date: June 27, 2014	/s/ Brent D. Bailey
	Brent D. Bailey, President and Chief Executive Officer and Director


Date: June 27, 2014	/s/ Jole Deal
	Jole Deal Vice President—Finance & Administration and CFO (Principal Financial and Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.